Pharmacokinetics and Bioequivalence of Molnupiravir, 200 mg Capsules and Lagevrio, 200 mg Capsules in Healthy Volunteers
Clinical trial NCT05412173 · COMPLETED
Trial details
- NCT number
- NCT05412173
- Sponsor
- Valenta Pharm JSC
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2022-04-22
- Primary completion
- 2022-05-17
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.